This inventor holds 3 USPTO granted patents. Top assignee: Genzyme Corporation. Active years: 1998-2003.
Location History:
- Westboro, MA (US) (1998)
- Framingham, MA (US) (2003)
Company Filing History:
Years Active: 1998-2003
Title: Helen Romanczuk: Innovator in Gene Therapy
Introduction
Helen Romanczuk is a prominent inventor based in Westboro, MA (US). She has made significant contributions to the field of gene therapy, holding a total of 3 patents. Her work focuses on developing advanced adenoviral vectors that enhance the safety and efficacy of gene therapy applications.
Latest Patents
Helen's latest patents include innovative technologies that address critical challenges in gene therapy. One of her notable inventions is related to adenoviral helper vectors. This invention is directed to improved helper vectors and cell lines for the production of pseudoadenoviral (PAV) vectors, which contain substantially reduced levels of contaminating helper vector. The invention provides for helper vectors that enable the production of substantially helper vector-free PAV stocks, utilizing phag C31 recombinase recognition sequences to prevent helper vector packaging.
Another significant patent involves adenovirus vectors for gene therapy. This invention relates to novel adenovirus vectors designed to prevent the generation of replication-competent adenovirus (RCA) during in vitro propagation and clinical use. The invention also outlines methods for producing these novel virus vectors, maximizing safety for clinical applications where adenovirus vectors are used to transfer genes into recipient cells for gene therapy.
Career Highlights
Helen Romanczuk is currently associated with Genzyme Corporation, where she continues to advance her research in gene therapy. Her work has been instrumental in developing safer and more effective gene transfer methods, contributing to the broader field of biotechnology.
Collaborations
Throughout her career, Helen has collaborated with notable colleagues, including Samuel C. Wadsworth and Donna Armentano. These collaborations have further enriched her research and innovation in the field.
Conclusion
Helen Romanczuk is a trailblazer in the field of gene therapy, with her innovative patents paving the way for safer and more effective treatments. Her contributions continue to impact the biotechnology industry positively.